InBios receives Emergency Use Authorization for its Smart Detect SARS-CoV-2 rRT-PCR Kit for detection of the virus causing COVID-19
April 08, 2020InBios International, Inc. announces the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-CoV-2
